Cost-effectiveness Analysis of Xueshuantong for Injection versus Ginkgo Leaf Extract and Dipyridamole In-jection in the Treatment of Ischemic Stroke
10.6039/j.issn.1001-0408.2015.36.23
- VernacularTitle:注射用血栓通对比银杏达莫注射液治疗缺血性脑卒中的成本-效果分析
- Author:
Bei GAO
;
Min MENG
;
Jing YU
;
Rina SA
;
Yan YANG
;
Bin GE
;
Hongru ZHAO
- Publication Type:Journal Article
- Keywords:
Xueshuantong injection;
Ginkgo leaf extract and dipyridamole injection;
Ischemic stroke;
Cost-effectiveness analy-sis
- From:
China Pharmacy
2015;26(36):5105-5107
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare pharmacoeconomic and effect of Xueshuantong for injection and Ginkgo leaf extract and dipyridamole injection in the treatment of ischemic stroke. METHODS:Retrospective study was conducted. Totally 404 inpatients with ischemic stroke were divided into Xueshuantong group(271 cases)and ginkgo leaf extract and dipyridamole group(133 cas-es) according to clinical treatment programs. Based on the conventional treatment,patients in 2 groups were given Xueshuantong for injection and ginkgo leaf extract and dipyridamole injection,respectively. The average treatment course was 10 d. Cost-minimi-zation analysis was performed with the determination index of total effective rate. RESULTS:The total effective rates in Xueshuan-tong group and ginkgo leaf extract and dipyridamole group were 90.77% and 88.72%,respectively,the difference was not statisti-cally significant(P>0.05). The costs in 2 groups were 12 860.21 yuan and 13 155.40 yuan,respectively,and xueshuantong group had lower than ginkgo leaf extract and dipyridamde group. CONCLUSIONS:Both Xueshuantong for injection and Ginkgo leaf ex-tract and dipyridamole injection are effective in the treatment of ischemic stroke. However,the economy of Xueshuantong for injec-tion is superior to the other one.
